Mirae Asset Capital Life Science Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 6

  • Portfolio
  • 3

  • Exits
  • 3

Exits

Mirae Asset Capital Life Science General Information

Company Description

Founded in 2023, Mirae Asset Capital Life Science is a US-based venture capital firm investing in life science companies.

Business Details

Website
www.lifesci.miraeasset.com
Year Founded
2023
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 131 Dartmouth Street
  • 3rd Floor
  • Boston, MA 02116
  • United States

Mirae Asset Capital Life Science Investments (6)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Dren Bio 29-Oct-2026 Later Stage VC Drug Discovery Clinical Trials - Phase 2
Precede Biosciences 30-Oct-2025 Biotechnology Generating Revenue
Attovia Therapeutics 30-Mar-2025 Drug Discovery Generating Revenue/Not Profitable
Candid Therapeutics 20-Aug-2024 Drug Discovery Clinical Trials - Phase 1
Vignette Bio 07-Aug-2024 Early Stage VC Drug Discovery Product Development
Accent Therapeutics 20-Dec-2023 Later Stage VC Drug Discovery Clinical Trials - Phase 1
To view Mirae Asset Capital Life Science’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mirae Asset Capital Life Science Exits (3)

Company Name Exit Date Exit Type Exit Size
Attovia Therapeutics 05-Aug-2026 IPO
Candid Therapeutics 01-Mar-2026
Vignette Bio 19-Aug-2024
To view Mirae Asset Capital Life Science’s complete exits history, request access »

Mirae Asset Capital Life Science Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Mirae Asset Capital Life Science Co-Investors (63)

Name With Exits Lead Partner Series Industry
EcoR1 Capital 2 Series chart Industry bar
Foresite Capital Series chart Industry bar
OrbiMed Series chart Industry bar
Qiming Venture Partners Series chart Industry bar
venBio Series chart Industry bar
You’re viewing 5 of 63 co-investors. Get the full list »

Mirae Asset Capital Life Science FAQs

  • What is Mirae Asset Capital Life Science?

    Founded in 2023, Mirae Asset Capital Life Science is a US-based venture capital firm investing in life science companies.

  • When was Mirae Asset Capital Life Science founded?

    Mirae Asset Capital Life Science was founded in 2023.

  • Where is Mirae Asset Capital Life Science headquartered?

    Mirae Asset Capital Life Science is headquartered in Boston, MA.

  • How many investments has Mirae Asset Capital Life Science made?

    Mirae Asset Capital Life Science has made 6 investments.

  • What has Mirae Asset Capital Life Science invested in?

    Mirae Asset Capital Life Science has made numerous investments in companies like Dren Bio, Precede Biosciences, and Attovia Therapeutics within the Drug Discovery and Biotechnology industries.

  • What has Mirae Asset Capital Life Science invested in recently?

    Mirae Asset Capital Life Science's latest investment was on 29-Oct-2026 in Dren Bio, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process